Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alcohol hand sanitizer foam is a topical antimicrobial product developed by Solventum (formerly 3M Health Care) for use in healthcare settings. It is formulated as a foam to facilitate rapid hand disinfection and improve compliance among healthcare workers. The active ingredient, typically ethyl alcohol (ethanol), works by denaturing microbial proteins and disrupting lipid-based cell membranes, effectively killing a broad spectrum of bacteria and viruses. This product is specifically designed for use in high-risk areas like Intensive Care Units (ICUs) to reduce the transmission of healthcare-associated infections. It is often compared to chlorhexidine-based antiseptics to evaluate its immediate efficacy and lack of persistent antimicrobial activity on the skin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alcohol hand sanitizer foam.